Literature DB >> 8892193

CT evaluation of fibrosing alveolitis--applications and insights.

D M Hansell1, A U Wells.   

Abstract

The clinical management of patients with fibrosing alveolitis has traditionally been empirical; without lung biopsy, a definitive diagnosis may be impossible and decisions about treatment are often arbitrary. With the advent of high-resolution computed tomography (CT), the proportion of patients needing lung biopsy for confirmation of the diagnosis of fibrosing alveolitis has declined. There is now much evidence that CT provides an accurate guide to disease activity, and more recent work has shown the important role of CT in providing new insights into the biologic behaviour and pathogenesis of fibrosing alveolitis.

Entities:  

Mesh:

Year:  1996        PMID: 8892193     DOI: 10.1097/00005382-199623000-00001

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  3 in total

Review 1.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 3.  Clinical use of biomarkers of survival in pulmonary fibrosis.

Authors:  Michiel Thomeer; Jan C Grutters; Wim A Wuyts; Stijn Willems; Maurits G Demedts
Journal:  Respir Res       Date:  2010-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.